Who owns SILEXION THERAPEUTICS CORP?

Tip: Access positions for across all investors

Analyze quarterly positions in Silexion Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Silexion Therapeutics Corp stock

Who bought or sold SILEXION THERAPEUTICS CORP this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Polar Securities 744k $19k 0% Dec 2025
 View chart
Linden Advisors 338k $8.6k 0% Dec 2025
 View chart
Aristeia Capital 237k $6.3k 0% Dec 2025
 View chart
Security Benefit Life Insurance 150k $4.1k 0% Dec 2025
 View chart
Goldman Sachs Group 121k $3.2k 4% Dec 2025
 View chart
Kepos Capital 100k $3.0k 0% Dec 2025
 View chart
Jane Street 75k $1.9k 0% Dec 2025
 View chart
Picton Mahoney Asset Management 57k $1.5k 0% Dec 2025
 View chart
Context Capital Management 51k $1.3k 0% Dec 2025
 View chart
Tenor Capital Management 50k $1.3k 0% Dec 2025
 View chart
Gabelli Securities 38k $991.900000 0% Dec 2025
 View chart
DuPont Capital Management Corporation 33k $884.000000 0% Dec 2025
 View chart
Neuberger Berman Group 32k $820.352000 0% Dec 2025
 View chart
Gabelli Funds 31k $792.896000 0% Dec 2025
 View chart
Mint Tower Capital Management B.V. 25k $1.0k 0% Dec 2025
 View chart
Hrt Financial 21k $0 100% Dec 2025
 View chart
Stifel Financial 16k $416.000000 0% Dec 2025
 View chart
DeepCurrents Investment Group 14k $27k 0% Dec 2025
 View chart
Millennium Management 13k $325.000000 0% Dec 2025
 View chart
Blue Owl Capital Holdings 13k $375.000000 100% Dec 2025
 View chart
Saba Capital Management 12k $317.524200 0% Dec 2025
 View chart
Oasis Management 11k $21k 0% Dec 2025
 View chart

Who sold out of Silexion Therapeutics Corp?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2025 220k $7.7k
Hartree Partners Sep 2025 182k $7.3k